CSI Market
Sign In | Register

Sigyn Therapeutics Inc (RSAP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RSAP Annual Balance Sheets →
The table below presents a historical view of Sigyn Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent0.09
Cash & Short-term Investments0.00
Inventories0.00
Other Current Assets0.00
Total Current Assets0.09
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.05
Operating Lease Right Of Use Asset-
Total Assets0.14
Liabilities
Accounts Payable, Current AC0.77
Accrued Payroll Taxes, Current2.28
Derivative Liability, Current DE0.18
Short-term Debt DE10.30
Other Liabilities, Current0.45
Total Current Liabilities3.99
Long-term debt2.06
Total Long-term Debt2.06
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent-
Total Liabilities6.05
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock11.46
Retained Earnings / Accumulated Deficit-17.38
Other Equity0.00
Common Stockholder's Equity-5.92
Total Stockholder's Equity-5.92
Liabilities & Stockholder's Equity0.14
4 historic quarters locked

Sign in to unlock the full Sigyn Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Sigyn Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250930)
  • Filed with the SEC: November 14, 2025
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-25-023387

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.